Incyte Strikes Deals with Schering-Plough, Pfizer; Licenses Patented Tech | GenomeWeb

PALO ALTO, Calif.--Incyte Pharmaceuticals announced a broad genomic data collaboration that provides Schering-Plough with access to Incyte's microarray technology and databases. Incyte will provide Plough with data from custom and prefabricated DNA microarrays in exchange for technology access and per-array fees. The multiyear collaboration also provides Plough with access to Incyte's LifeSeq gene sequence and expression database and the LifeSeq FL database of full-length genes. Financial terms of the agreement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.